In this online self-learning activity:
Growth hormone deficiency (GHD), a condition characterized by inadequate endogenous production, may arise from manifold etiologies such as tumors, radiation, medications, or traumatic brain injury and occurs in about one out of every 4,000 children. The differential diagnosis includes hypothyroidism, Turner syndrome, and familial short stature among others. The most up-to-date guidance on treatment of pediatric GHD has been published relatively recently, and research suggests that healthcare professionals are oftentimes unable to keep up with the steady publishing of literature and evolution of clinical practice.
The following healthcare professionals: endocrinologists, pediatricians, and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in endocrinology; and any other healthcare professionals with an interest in or who clinically encounter patients with GHD.
This program is supported by an educational grant from Novo Nordisk.
Release Date: February 14, 2018 -- Expiration Date: February 14, 2020
Faculty: Michael Yafi, MD
A review primer: epidemiologic, pathophysiologic, etiologic features, and clinical signs and symptoms
Treatment options available for GHD
By the end of the session the participant will be able to:
THIS COURSE HAS EXPIRED. NO CREDIT WILL BE ISSUED FOR COMPLETING IT.
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.
Faculty Disclosure: Michael Yafi, M.D., Director, Division of Pediatric Endocrinology, Assistant Professor, The University of Texas - Houston Health Science Center, has no relevent financial disclosures.
Disclosures of Educational Planners: Charles Turck, PharmD, BCPS, BCCCP has no relevent financial disclosures.
Commercial Support Disclosure: This program is supported by an educational grant from Novo Nordisk.
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.
The Current and Emerging Landscape of Adult Growth Hormone Deficiency (AGHD) Pharmacotherapy